Technical Information

  • CAS no.: 635702-64-6
  • Type: API

  • Usage: Advanced renal cell carcinoma (RCC)

  • Technical description
    Parecoxib Sodium is a water-soluble, injectable sodium salt form of parecoxib, an amide prodrug of the cyclooxygenase II (COX-2) selective, non-steroidal anti-inflammatory drug (NSAID) valdecoxib, with anti-inflammatory, analgesic, and antipyretic activities. Upon intravenous or intramuscular administration, parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib. Valdecoxib selectively binds to and inhibits COX-2. This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever. This NSAID does not inhibit COX-1 at therapeutic concentrations and, therefore, does not interfere with blood coagulation.

  • IUPAC name: 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride.

  • Molecular formula: C21H24ClN7O2S

  • Molecular Weight: 474.0 g/mol

  • Class: A tumor growth inhibitor, specifically a multi-target protein kinase inhibitor.

  • Synonyms: LGW786034 / GW-786034 / GW786034B / GW786034 HCl.

All products

FOR ANY INFORMATION,
CONTACT US